QA: Zosano Pharma Corp in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001587221_2021_Zosano_Pharma_Corp.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001587221, Zosano Pharma Corp

  xvar xval
0 AssetsCurrent 35,716,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 30,909,000
3 remainder_Assets 5,386,000
4 LiabilitiesCurrent 14,511,000
5 LiabilitiesNoncurrent 5,626,000
6 remainder_Liabilities 4,359,000
7 CostOfGoodsAndServicesSold 171,000
8 SellingGeneralAndAdministrativeExpense 11,063,463
9 ResearchAndDevelopmentExpense 21,759,813
10 remainder_Expenses 828,710
11 remainder_Revenues 146,999
12 remainder_NetIncome 112,988
13 remainder_ComprehensiveNetIncome 1,728
  yvar yval
0 Assets 72,011,000
1 Liabilities 24,496,000
2 Expenses 33,822,986
3 Revenues 146,999
4 StockholdersEquity 47,515,000
5 NetIncome -33,562,999
6 ComprehensiveNetIncome -33,562,135
7 BaseVar 65,295,850
8 EconomicCapitalRatiobeforeLimitedLiability 1.45
9 EconomicCapitalRatio 2.64

Edgar->Model Mapping

Feature Distribution

Change over Time